Dutch food-tech company Revyve has closed a Series B financing round at nearly €24 million. This significant investment brings their total capital raised to over €40 million. Co-leading the Series B were ABN AMRO Sustainable Impact Fund and Invest-NL, with additional regional support provided by Brabantse Ontwikkelings Maatschappij (BOM). Strategic investments also came from Danstar Ferment, a Swiss affiliate of Lallemand Bio-Ingredients, and Grey Silo Ventures, the corporate venture capital arm of Cereal Docks Group. And existing investors Oost NL and Royal Cosun significantly increased their commitments, reinforcing their belief in Revyve’s potential.
This funding will be used to advance the commercial launch and expansion of their functional yeast proteins, which are specifically designed to replace traditional eggs and various additives across a wide range of popular food categories. And this mix of investors highlights Revyve’s ambitious goal of transforming the alternative protein sector by offering advanced, clean-label solutions for the next generation of food products.
Revyve is at the forefront of developing highly functional yeast proteins that are capable of replicating the performance of eggs in numerous food applications. These include essential categories like bakery items, sauces, alternative meat products, and plant-based dairy. What sets Revyve’s ingredients apart from many other substitutes is their natural composition, enhanced sustainability profile, and competitive pricing. These characteristics empower food manufacturers to effectively address three critical challenges currently facing the industry. Firstly, the volatile and often rising costs of eggs have created an urgent demand for more affordable and price-stable alternatives. Secondly, increasing public and regulatory scrutiny of ultra-processed foods is compelling brands to remove artificial additives while preserving product functionality. Lastly, the growing emphasis on sustainability means major retailers and food manufacturers are actively seeking ways to reduce their carbon dioxide footprints throughout their entire supply chains. Revyve’s solutions offer a compelling answer to these pressing industry needs.
In a significant step towards scaling its operations, Revyve commissioned its pioneering first-of-a-kind production facility in Dinteloord, located in the Netherlands, during 2024. This facility is already operating at full capacity, serving multiple customers, and has successfully demonstrated the company’s capability to produce and sell industrial volumes of its innovative products.
With this new funding, Revyve plans to substantially expand its output to more than 1,600 tons per year, ensuring a reliable supply for its global client base. The strong regional support from both the Wageningen and Brabant ecosystems has been instrumental in enabling Revyve to scale to industrial production levels in an exceptionally short timeframe. With a highly skilled team and robust investor backing, the company is exceptionally well-positioned for significant global expansion.
The involvement of Lallemand Bio-Ingredients and Grey Silo Ventures, the corporate venture capital arm of Cereal Docks Group, further strengthens Revyve’s Series B round. These strategic partners bring invaluable knowledge and synergistic expertise in the fields of yeast innovation and the broader agri-food sector.
KEY QUOTES:
“Food manufacturers are cutting back on eggs to offset increasing prices and reach sustainability targets, but replicating their unique functionality is crucial to maintaining the texture and mouthfeel consumers are used to. This is exactly where our Yeast Proteins come in, providing an affordable and clean label solution for egg replacement or egg reduction. This funding round marks a tipping point for us: allowing us to modularly scale production and branch out to more food categories and serve our sustainable solutions to larger customers worldwide”
Cedric Verstraeten, CEO of Revyve
“We are excited to partner with Revyve as they pioneer pressing sustainable alternatives to traditional egg ingredients. Their solution addresses a critical need in the food transition: scalable ingredients with a low environmental footprint and compelling economics for food manufacturers. We believe this combination of commercial viability and measurable sustainable benefits makes Revyve uniquely positioned to grow into a global leader. We look forward to supporting their journey.”
Hanna Zwietering, ABN AMRO SIF Senior Investment Manager
“With their functional egg-replacement ingredients, Revyve can play a major role in accelerating the global protein transition and fostering circular solutions that reduce pressure on land, water and animals. We are proud to invest in this Dutch company, which strengthens the country’s innovative power with a pioneering technology that has the potential to transform food production worldwide.”
Lisette Kersting-van der Boog, Senior Investment Manager of Invest-NL
“Revyve’s plans align seamlessly with our mission to position Brabant as the Scale-Up Plant of Europe. Their breakthrough technology not only contributes to a more sustainable food system but also exemplifies the kind of bold innovation we aim to foster in the region. We’re proud to support Revyve in scaling their impact from Brabant to the world.”
Ingrid Nieweg, Investment Manager at BOM
